ALK POSITIVE
Clinical trials for ALK POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK POSITIVE trials appear
Sign up with your email to follow new studies for ALK POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests the safety and best dose of two drugs, ceritinib and everolimus, given together to adults with advanced solid tumors or a specific type of lung cancer (ALK-positive NSCLC). The goal is to find the highest safe dose and see if the combination can shrin…
Matched conditions: ALK POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Targeted pill after surgery may keep ALK lung cancer from returning
Disease control OngoingThis study looks at whether taking crizotinib after surgery can help people with early-stage ALK-positive non-small cell lung cancer live longer without the cancer coming back. About 166 patients who had their tumor removed will either take crizotinib pills or just be watched. Th…
Matched conditions: ALK POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC